Several corporate developments are expected to be in focus in the equity markets on February 25, 2026, including quarterly earnings announcements, stake sales, large order wins, regulatory updates, and global agreements across the pharma, railway, infrastructure, renewable energy, and technology sectors.
Quarterly Earnings Announcements
Financial results are scheduled to be announced by KSB, Sanofi India, Sanofi Consumer Healthcare India, AJC Jewel Manufacturers, Foseco India, Subam Papers, Supha Pharmachem and Vasudhagama Enterprises.
Government Stake Sale in Indian Railway Finance Corporation
The central government will sell a 2 percent stake in Indian Railway Finance Corporation on February 25 and 26 through an offer for sale on the BSE and NSE. Approximately 26.13 crore equity shares will be made available, with an option to sell an additional equal stake if required.
The floor price for the sale has been fixed at Rs 104 per share.
Waaree Energies Subsidiary Secures 300 MW Wind Project
Waaree Energies’ subsidiary, Waare Forever Energy, has received a Letter of Award from Solar Energy Corporation of India for the development of a 300 megawatt wind energy project in Dwarka, Gujarat.
Lupin Receives US FDA Approval
Lupin has received approval from the US Food and Drug Administration for Brivaracetam Oral Solution, indicated for the treatment of partial-onset seizures in epilepsy.
The annual sales of the drug in the US market are estimated at approximately $135 million.
Rail Vikas Nigam Limited Wins Central Railway Order
Rail Vikas Nigam Limited has received an order worth Rs 270.22 crore from Central Railway. The project involves construction of a traction substation and associated electrical infrastructure in the Daund-Solapur section.
HG Infra Engineering Declared Lowest Bidder for NHAI Project
HG Infra Engineering has been declared the lowest bidder for a Rs 1,582 crore project for the construction of a six-lane access-controlled ring road in Odisha. The project will be executed under the Hybrid Annuity Model.
Dr. Reddy’s Laboratories Receives Communication from US SEC
Dr. Reddy’s Laboratories has received a letter from the US Securities and Exchange Commission stating that, based on the available facts, no enforcement action is being recommended at this time.
The company had earlier been under investigation over alleged irregular payments in certain countries, including Ukraine.
Meta Platforms Signs AI Chip Agreement with AMD
Meta Platforms has entered into an agreement with AMD for the purchase of artificial intelligence chips to support data center expansion. The potential value of the deal could exceed $100 billion.
Eris Lifesciences Signs Distribution Agreement for Semaglutide
Eris Lifesciences has entered into an agreement with Natco Pharma for the commercial distribution of semaglutide in India. Natco recently received regulatory approval, and the drug is scheduled for launch by March 2026.
The drug will be used for the treatment of Type 2 diabetes.
Reliance Retail Identified as Largest Unlisted Company by Revenue
According to a report, Reliance Retail has been identified as the country’s largest unlisted company by revenue, followed by Flipkart and Malabar Gold & Diamonds.
The combined revenue of the top 100 private companies reached Rs 8.9 lakh crore in 2025. Fast-growing companies included Tata Electronics, Tata Passenger Electric Mobility and JSW One Platforms.
